Jeff Evanson
Chief Commercial Officer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Outlook Therapeutics, Inc. (OTLK)
Proxy statement
Start not stated–2025-09-05
-
Outlook Therapeutics, Inc. (OTLK)
Proxy statement
Start not stated–2025-09-05
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Outlook Therapeutics, Inc. (OTLK) | Former Chief Commercial Officer | $420,577 | $1,159,107 |
| 2024 | Outlook Therapeutics, Inc. (OTLK) | Former Chief Commercial Officer | $450,000 | $768,029 |
| 2023 | Outlook Therapeutics, Inc. (OTLK) | Chief Commercial Officer Terry Dagnon Former Chief Operations Officer | $450,000 | $718,195 |
| 2022 | Outlook Therapeutics, Inc. (OTLK) | Chief Commercial Officer Terry Dagnon Former Chief Operations Officer | $353,077 | $1,408,961 |
| 2021 | Outlook Therapeutics, Inc. (OTLK) | Chief Commercial Officer | — | $300,000 |
| 2020 | Outlook Therapeutics, Inc. (OTLK) | Chief Commercial Officer | — | $159,677 |
| 2019 | Outlook Therapeutics, Inc. (OTLK) | Chief Commercial Officer | — | — |
| 2018 | Outlook Therapeutics, Inc. (OTLK) | Chief Commercial Officer | — | — |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.